|
CAMSAP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.88290000000225E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.196500E-04 |
| Normal-vs-Stage2 |
1.369960E-01 |
| Normal-vs-Stage3 |
3.299900E-03 |
| Normal-vs-Stage4 |
1.846250E-02 |
| Stage1-vs-Stage2 |
9.310800E-01 |
| Stage1-vs-Stage3 |
7.936200E-01 |
| Stage1-vs-Stage4 |
9.624800E-01 |
| Stage2-vs-Stage3 |
8.239400E-01 |
| Stage2-vs-Stage4 |
9.136000E-01 |
| Stage3-vs-Stage4 |
8.860400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.86289999995581E-06 |
| Normal-vs-AfricanAmerican |
1.021790E-01 |
| Normal-vs-Asian |
9.806000E-02 |
| Caucasian-vs-AfricanAmerican |
6.237200E-01 |
| Caucasian-vs-Asian |
1.135850E-01 |
| AfricanAmerican-vs-Asian |
6.307400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.511900E-02 |
| Normal-vs-Female |
5.92299999999657E-05 |
| Male-vs-Female |
1.891400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.198880E-04 |
| Normal-vs-Age(41-60Yrs) |
2.498500E-03 |
| Normal-vs-Age(61-80Yrs) |
5.605900E-02 |
| Normal-vs-Age(81-100Yrs) |
8.195200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.740000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.517400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.041200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.678400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.684200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.060200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.587600E-01 |
| Classical-VS-Follicular |
2.79887224508002E-13 |
| Classical-VS-Other |
2.157200E-01 |
| Classical-VS-Normal |
3.59880000244672E-08 |
| Tall-VS-Follicular |
2.97220000000653E-06 |
| Tall-VS-Other |
1.848240E-01 |
| Tall-VS-Normal |
3.184300E-03 |
| Follicular-VS-Other |
2.949200E-01 |
| Follicular-VS-Normal |
2.535800E-02 |
| Other-VS-Normal |
8.601600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.331700E-02 |
| Normal-vs-N1 |
1.526640E-01 |
| N0-vs-N1 |
9.108600E-01 |
|
|
